This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CareFusion Strengthens U.K. Presence With Acquisition Of Medical Products Distributor

SAN DIEGO, June 7, 2012 /PRNewswire/ --  CareFusion today announced the acquisition of U.K. Medical Limited, a leading distributor of medical products to the National Health Service (NHS) and private health care sector in the United Kingdom. Terms of the deal were not disclosed.

The acquisition, the company's fifth, is part of CareFusion's strategy to expand globally by investing to build scale, infrastructure and local capabilities in key markets. U.K. Medical has strong customer relationships and clinical marketing expertise with specialized medical technologies including products used in interventional radiology and for surgical and vascular access in acute-care hospitals.

"The acquisition further strengthens CareFusion's presence in the United Kingdom, where we have built leadership positions in infusion therapy and infection prevention," said Gordon LaFortune, executive vice president of International Commercial Operations for CareFusion. "We believe this acquisition will help us expand our long-standing partnership with U.K. Medical and better leverage the company's clinical expertise to continue to grow our Procedural Solutions business in the United Kingdom and beyond."

U.K. Medical primarily serves the National Health Service and focuses on distribution of clinically differentiated interventional and implantable single-use medical products for biopsy, cardiac, drainage, obstetrics and gynecology, non-vascular stenting, surgery and vertebroplasty. The company served as the sole U.K. distributor of CareFusion's Interventional Technologies portfolio, including soft-tissue and bone marrow biopsy needles, the AVAmax® Advanced Vertebral Augmentation System and the PleurX® Peritoneal Catheter Drainage System, which the National Institute for Health and Clinical Excellence (NICE) recently supported through published guidance for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites. Over the past three years, U.K. Medical has contributed to a nearly 50 percent growth of CareFusion's Interventional Technologies portfolio in the United Kingdom. The company also markets medical products for approximately 10 additional suppliers.

"For more than 30 years, we have served the NHS and private medical sector with high-quality, high-technology medical products to help improve patient care pathways," said Jim Mackenzie, chairman of U.K. Medical. "We look forward to continuing our track record of growth and innovation with CareFusion."

U.K. Medical has nearly 40 employees and is headquartered in Sheffield, United Kingdom. CareFusion currently employs approximately 350 people in the United Kingdom.

About CareFusionCareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, Air Life™ and LTV® series ventilation and respiratory products, ChloraPrep® skin prep products, MedMined® services for data mining surveillance, Nicolet™ neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 14,000 people across its global operations. More information may be found at


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs